Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, one has given a hold recommendation, four have issued a buy recommendation and one has given a strong buy recommendation to the company.
A number of equities research analysts have issued reports on SAUHY shares. BMO Capital Markets assumed coverage on Straumann in a research report on Wednesday, July 8th. They issued an “outperform” rating on the stock. The Goldman Sachs Group raised Straumann from a “neutral” rating to a “buy” rating in a research report on Monday, September 14th. Citigroup restated a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. Finally, UBS Group raised shares of Straumann from a “neutral” rating to a “buy” rating in a report on Tuesday, September 1st.
Get Our Latest Report on Straumann
Straumann Price Performance
Shares of SAUHY opened at $11.29 on Wednesday. Straumann has a 1 year low of $9.44 and a 1 year high of $13.61. The company’s 50-day simple moving average is $11.50 and its 200-day simple moving average is $11.72.
About Straumann
Straumann Group is a Switzerland-based dental technology company headquartered in Basel. Founded in 1954, the company develops, manufactures and distributes products used in tooth replacement, restorative dentistry and oral tissue regeneration. Its offerings are designed for dental professionals, laboratories and patients across a range of clinical applications.
The company’s portfolio includes dental implants, implant-supported prosthetics, biomaterials for bone and tissue regeneration, orthodontic aligners and digital dentistry solutions.
See Also
- Five stocks we like better than Straumann
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
